By Ediberto Roman | May 8, 2024
"The DOJ and FTC's misguided suit against RealPage is not supported by antitrust jurisprudence, and $7 trillion in economic growth is on the line," writes Ediberto Roman, professor of law at Florida International University.
By Sahil Garg, Proxiio | May 8, 2024
The use of data analytics in legal processes is no longer optional, but crucial as it advances. With these tools at their disposal, lawyers can approach litigation with a data-driven strategy, rather than relying just on luck and hours of manual review.
The Legal Intelligencer | Commentary
By Benjamin P. Sheppard | May 8, 2024
The judicial landscape, at both the state and federal levels, is tasked with determining the existence of a private cause of action under each state's medical cannabis statute. This determination hinges on whether the statute delegates enforcement responsibilities to a governmental entity, or if it lacks an independent mechanism for addressing employer violations.
Daily Business Review | Commentary
By Todd J. Michaels | May 8, 2024
In the 22 years that I have had the honor of representing clients in courts throughout Florida, I have rarely seen a jury get it wrong.
New Jersey Law Journal | Commentary
By Rahool Patel | May 8, 2024
"The strength of New Jersey's attorney disciplinary system depends on attorneys like you," writes Rahool Patel.
Daily Business Review | Commentary
By Julio E. Ligorría | May 8, 2024
By leveraging the expertise of PR professionals, lawyers can transform their communication into a strategic tool, attracting new clients, enhancing their reputation, and ultimately achieving lasting success.
The Legal Intelligencer | Commentary
By Rich Lee | May 8, 2024
For this month's feature, I had the pleasure of speaking with Robyn Weinstein, who has dedicated her career to the advancement and craft of conflict resolution.
By Elisa Reiter and Daniel Pollack | May 8, 2024
"Was the difference significant enough to lead to a legally required prorated tuition refund?" write Elisa Reiter and Daniel Pollack.
Connecticut Law Tribune | Commentary
By Ashley Picker Dubin | May 7, 2024
The implications extend beyond the courtroom and into broader societal concerns, particularly regarding access to justice.
The Legal Intelligencer | Commentary
By Tariq Naeem | May 7, 2024
Momentum has been gathering behind efforts to reclassify marijuana under the Controlled Substances Act (CSA). Regardless of how marijuana is rescheduled under federal law, the Food and Drug Administration (FDA) could consider medical marijuana products to be unapproved "new drugs" subject to regulation under the Food, Drug, and Cosmetic Act (FDCA).
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Seeking a compassionate and experienced estate administration attorney for growing boutique estate planning and elder law practice. Huge eq...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS